Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression (2006)
- Authors:
- Autor USP: MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Abstract: Introduction and Aims: Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by clonal expansion of neoplastic hematopoietic stem cell, the neogene Bcr-Abl is a hallmark of CML. PRAME (Preferentially Expressed Antigen in Melanoma) was first described as an antigen in human melanoma, which triggers autologous cytotoxic T cell-mediated immune responses. The correlation between the bcr-abl and prame expression has previously been suggested but this association is still unclear. Our goals were to determine the possible correlation among prame expression, Bcr-Abl levels, CML progression, and response to imatinib (Gleevec ® ). Methods and Results: prame expression was evaluated in many cell lines, such as HL-60, HL-60.BcrAbl, HeLa, HeLa.BcrAbl, Jurkat, Jurkat.BcrAbl, K562, KBM5, KBM7, KCL22, LAMA-84, SKW.64, SKW.BcrAbl, THP1, and THP1.BcrAbl (with or without imatinib) and 22 CML patients in different phases and in cytogenetic remission post-imatinib by real-time RT-PCR. We found a correlation between bcr-abl and prame in HL-60 X HL-60.BcrAbl in which prame expression was 48-times higher in HL-60.Bcr-Abl.Moreover, we did not detect any association between imatinib treatment and prame expression, which support that this is independent of the Bcr-Abl tyrosine kinase activity. On the other hand, a higher prame expression was related to disease progression. This gene expression was 8-times and 29-times higher inaccelerated and blastic phase than in chronic phase, respectively. Prame levels were lower in post-imatinib cytogenetic remission patients when comparing to refractory patients. Conclusion: Tyrosine kinase-independent prame expression and its correlation with disease progression suggest that PRAME might be involved in Bcr-Abl mediated leukemogenesis. Besides, prame was recently described as a dominant repressor of retinoic acid receptor (RAR). Signaling through RAR induce growth arrest, differentiation, and apoptosis in many cell types. Taken these data together, new treatments can be developed, aiming to inhibit the function or expression of prame, for the most delayed phase, in imatinib-refractory patients.
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Meeting of the Brazilian Society for Immunology
-
ABNT
CARVALHO, D D et al. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. 2006, Anais.. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2006. . Acesso em: 13 fev. 2026. -
APA
Carvalho, D. D., Proto-Siqueira, R., Leroy, J. M. G., Pereira, W. O., Bueno-da-Silva, A. E., Jacysyn, J. F., et al. (2006). Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. In Abstracts. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Carvalho DD, Proto-Siqueira R, Leroy JMG, Pereira WO, Bueno-da-Silva AE, Jacysyn JF, Zanichelli MA, Camanho D, Collassanti MD, Hamerschlak N, Zago MA, Castro FA, Amarante-Mendes JGP. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. Abstracts. 2006 ;[citado 2026 fev. 13 ] -
Vancouver
Carvalho DD, Proto-Siqueira R, Leroy JMG, Pereira WO, Bueno-da-Silva AE, Jacysyn JF, Zanichelli MA, Camanho D, Collassanti MD, Hamerschlak N, Zago MA, Castro FA, Amarante-Mendes JGP. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. Abstracts. 2006 ;[citado 2026 fev. 13 ] - Therapeutic applications of TRAIL receptor agonists in cancer and beyond
- Apoptosis: a programme of cell death or cell disposal?
- Endostatin-Bax: a novel fusion protein with enhanced antiangiogênic activity
- Apoptosis induced by manganese in hematopoietic cell lines
- Development and characterization of murine models of T lymphoma to investigate the impact of oncogene expression
- Overexpression of the anti-apoptotic genes mcl-1, bcl-w, bcl-xL and a1 is correlated with chronic myelogenous leukemia progression and resistance to gleevec
- Crosstalk between TCR activation and dexamethasone administration in NKT cells: similarities and differences to T lymphocytes
- Silenciamento do gene wasp na leucemia mielóide crônica: consequências na sobrevida dos pacientes e na resistencia à apoptose das células leucêmicas
- Activation of an apoptosis-like program during megakaryocitic and monocytic/macrophagic differentiation of hematopoietic cell lines
- Prostaglandin e2 and melatonin alter the expression of death receptor ligands in cd4+ t-cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
